Wall Street’s main indexes scored record closing highs on Friday and booked solid gains for the week following a strong jobs report. The S&P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for…
Australia Eyes National Rapid COVID-19 Test Plan
Hospitals, aged care facilities, and schools are among the high-risk settings where workers and visitors could face rapid COVID-19 testing under an Australian plan to be developed. National cabinet on Friday agreed the federal health department and Australian Health Protection Principal Committee will work on creating a nationally consistent framework for the use of rapid antigen tests….
Australia Vaccination Rate Reaches 80 Percent
Australia has officially reached 80 percent full vaccination against COVID-19, Prime Minister Scott Morrison has announced. Morrison said a further nine percent of the population aged 16 or over has also received a first vaccine dose although inoculation levels vary from state to state. Morrison has called the achievement “another magnificent milestone.” “A huge thank…
Facts Matter (Nov. 5): Whistleblower Exposes Data Integrity Issues in Pfizer’s Clinical Trial
According to its newly published earnings report, Pfizer is proverbially swimming in cash. In fact, both its revenue, as well as its profits, have more than doubled in the third quarter of this year, when you compare it to a year ago. And most of that growth, as you can guess, is being driven by…
Pfizer Says Antiviral Pill Reduces Risk of Hospitalization, Death From CCP Virus by 89 Percent
Pfizer Inc’s experimental oral antiviral COVID-19 pill “significantly” reduces the risk of hospitalization and death for high-risk patients, the U.S.-based pharmaceutical company announced on Friday. The drug, known as PAXLOVID, was found in a scheduled interim analysis to reduce the risk of hospitalization or death from the CCP (Chinese Communist Party) virus by 89 percent…
Wall Street Extends Record Rally on Strong Jobs Report
November 5, 2021
admin
Business & EconomyBusinesses in COVID-19Companieseconomic policiesEconomieseconomygainsinflationInvestmentjobsLocal NewsMarketsNew YorkNY NewsoctoberpayrollsPfizerpillRegional-Local NewsUSUS NewsWall Street
0 Comment
Wall Street’s main indexes hit record highs in a broad-based rally on Friday as data showing strong jobs growth in October, coupled with Pfizer’s COVID-19 pill update, boosted sentiment about economic growth. Ten of the 11 major S&P sectors advanced in early trading, with economy-sensitive energy, financials, and industrials gaining more than 1 percent each….
Report of Problems With Pfizer COVID-19 Vaccine Trial Being Investigated: Contract Company
The alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine trial are being probed, a contract company involved in the research has confirmed. Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson worked for the company during this time. She told the British Medical Journal (BMJ)…
CDC Panel Recommends All Children Between 5 and 11 Get Pfizer’s COVID-19 Vaccine
A Centers for Disease Control and Prevention (CDC) advisory panel on Tuesday advised the agency to recommend all children between 5 and 11 get Pfizer’s COVID-19 vaccine. Panel members said they were worried about post-vaccination incidence of heart inflammation seen in youth, especially males, but ultimately agreed with CDC scientists that the benefits of vaccinating…
CDC Recommends Children Between 5 and 11 Get Pfizer’s COVID-19 Vaccine
The Centers for Disease Control and Prevention (CDC) on Tuesday night recommended practically every child in the United States between 5 and 11 get Pfizer’s COVID-19 vaccine. CDC Director Dr. Rochelle Walensky made the recommendation, following advice from the agency’s vaccine advisory panel. “Together, with science leading the charge, we have taken another important step…
Pfizer’s Profits Surge on Soaring COVID-19 Vaccine Sales
November 2, 2021
admin
Business & EconomyCCP VirusCompaniesCOVID-19 vaccineearningsMarketsPfizerUSUS NewsVaccines & SafetyWorld
0 Comment
Pfizer reported that both sales and profits more than doubled in the third quarter of this year compared to the year-ago period, with the better-than-expected results coming on the back of soaring sales of its COVID-19 vaccine. In its Nov. 1 earnings report (pdf), Pfizer boasted third-quarter revenues of $24.1 billion, a 134 percent boost…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta